Sangeeta Srivastava

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Godavari Biorefineries Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sangeeta Srivastava. Retrieved from https://idiyas.com/inventor/sangeeta-srivastava

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 4.3

ph-index = 1

Location History:

Mumbai, IN (2018 - 2021)
Maharashtra, IN (2021 - 2023)

Company Filing History:

7 out of 8

Godavari Biorefineries Limited

patents

Years Active: 2018-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760010 - 5-hydroxy-1,4-naphthalenedione for use in the treatment of cancer (2026-10-13),

2. 12459930 - Compounds for the inhibition of unregulated cell growth (2025-11-04),

3. 11680078 - Anticancer compounds (2023-06-20),

4. 11124653 - Biofiller for rubber reinforcement (2021-09-21),

5. 11084843 - Anticancer compounds (2021-08-10),

6. 10954630 - Process for producing cellulose with low impurities from sugarcane bagasse (2021-03-23),

7. 9919318 - Process for preparation of high flash point frothing agent (2018-03-20),

Title: Sangeeta Srivastava: Innovator in Cancer Research

Introduction

Sangeeta Srivastava is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of cancer research, focusing on the development of innovative compounds aimed at inhibiting uncontrolled cell growth. With a total of 7 patents to her name, her work is paving the way for advancements in cancer treatment.

Latest Patents

Among her latest patents, Sangeeta has developed compounds specifically designed for the inhibition of unregulated cell growth, particularly targeting cancer stem cells. Her inventions include compounds of Formula I to XXII, which are intended for the treatment of various types of cancer. Additionally, she has disclosed anticancer compounds that inhibit uncontrolled cell proliferation, particularly in cancer stem cells, with a focus on breast and prostate cancer. These compounds are categorized under Formula III to XIV.

Career Highlights

Sangeeta currently works at Godavari Biorefineries Limited, where she continues to innovate and contribute to the field of biochemistry and cancer research. Her dedication to her work has established her as a key figure in the industry.

Collaborations

Sangeeta collaborates with talented individuals such as Maithili Athavale and Prashant Kharkar, who share her passion for advancing cancer research and developing effective treatments.

Conclusion

Sangeeta Srivastava's innovative work in cancer research exemplifies her commitment to improving healthcare through scientific advancements. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her dedication to this important cause.

Profile summary based on public USPTO records.